Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions

Journal of Virological Methods

Volumn 176, Issue 1-2, 2011, Pages 78-84

  Hadac, Elizabeth M ^a   Federspiel, Mark J ^a   Chernyy, Evgeny ^b   Tuzikov, Alexander ^b   Korchagina, Elena ^b   Bovin, Nicolai V ^b   Russell, Stephen ^a   Henry, Stephen M ^c  

^a MAYO CLINIC   (United States)

^b SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^c AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

Author keywords

Kodecyte; Kodevirion; Labeling; Virus

Indexed keywords

AGENTS USED IN FUNCTION TESTS; FUNCTION SPACER LIPID CONSTRUCT I 125; FUNCTION SPACER LIPID CONSTRUCT INCORPORATING FLUORESCEIN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD; CECUM; CHEMICAL LABELING; CHEMICAL STRUCTURE; CONTROLLED STUDY; FEMALE; HEART; IMAGING SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS A H1N1; INFUSION; INTESTINE; ISOTOPE LABELING; KIDNEY; LIVER; MEASLES VIRUS; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; RADIOIODINATION; SALIVARY GLAND; SPLEEN; STOMACH; SYNTHESIS; THYROID GLAND; TISSUE DISTRIBUTION; VESICULAR STOMATITIS VIRUS; VIRION; VIRUS ATTACHMENT; VIRUS INFECTIVITY;

ANIMALS; BIOLOGICAL MARKERS; CELL LINE; CERCOPITHECUS AETHIOPS; FEMALE; FLOW CYTOMETRY; FLUORESCEIN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFLUENZA A VIRUS, H1N1 SUBTYPE; IODINE RADIOISOTOPES; LIPIDS; MEASLES VIRUS; MICE; MICE, INBRED C57BL; STAINING AND LABELING; TISSUE DISTRIBUTION; VERO CELLS; VESICULAR STOMATITIS INDIANA VIRUS; VIRION;

MEASLES VIRUS; MUS; ORTHOMYXOVIRIDAE; VESICULAR STOMATITIS VIRUS;

EID: 79960592246     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.06.005     Document Type: Article

References (23)

1. Barr K., Diegel O., Parker S., Bovin N., Henry S. Function-Spacer-Lipid (FSL) constructs enable inkjet printing of blood group antigens. FEBS J. 2010, 277(S1):235.
2. Blake D., Lan A., Love D., Bovin N., Henry S. Fluorophore-kodecytes - fluorescent function-spacer-lipid (FSL) modified cells for in vitro and in vivo analyses. FEBS J. 2010, 277(S1):199.
3. Blake, D.A., Bovin, N.V., Bess, D., Henry, S.M., 2011. FSL constructs: a simple method for modifying cell/virion surfaces with a range of biological markers without affecting their viability. J. Vis. Exp. (in press).
4. Campos S.K., Parrot M.B., Barry M.A. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. Mol. Ther. 2004, 9:942-954.
5. Chesla S., Henry S., Eatz R., Sinor L. Solid phase syphilis test utilizing KODE technology. Transfusion 2010, 50(S1):196A-197A.
6. Frame T., Carroll T., Korchagina E., Bovin N., Henry S. Synthetic glycolipid modification of red blood cell membranes. Transfusion 2007, 47:876-882.
7. Hammond W.T., Bradley E.L., Welsh R.E., Qian J., Weisenberger A.G., Smith M.F., Majewski S., Saha M.S. A gamma camera re-evaluation of potassium iodide blocking efficiency in mice. Health Phys. 2007, 92:396-406.
8. Harrison A.L., Olsson M.L., Brad Jones R., Ramkumar S., Sakac D., Binnington B., Henry S., Lingwood C.C., Branch D.R. A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms. Glycobiology 2010, 27:515-524.
9. Heathcote D., Carroll T., Wang J.J., Flower R., Rodionov I., Tuzikov A., Bovin N., Henry S. Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto erythrocytes. Transfusion 2010, 50:635-641.
10. Henry S. Modification of red blood cells for laboratory quality control use. Curr. Opin. Hematol. 2009, 16:467-472.
11. Herschman H.R. Molecular imaging: looking at problems, seeing solutions. Science 2003, 302:605-608.
12. Kuruppu D., Tanabe K.K. Viral oncolysis by herpes simplex virus and other viruses. Cancer Biol. Ther. 2005, 4:524-531.
13. Lui T.-C., Galanis E., Kirn D. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress. Nat. Rev. Clin. Oncol 2007, 4:101-117.
14. Mochalova L., Gambaryan A., Romanova J., Tuzikov A., Chinarev A., Katinger D., Katinger H., Egorov A., Bovin N.V. Receptor-binding properties of modem human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs. Virology 2003, 313:473-480.
15. Oliver, C., Blake, D., Henry, S. Modeling transfusion reactions and predicting in vivo cell survival with kodecytes. Transfusion (in press). doi:10.1111/j.1537-2995.2010.03034.x.
16. Oliver, C., Blake, D., Henry, S. In vivo neutralization of anti-A and successful transfusion of incompatible red cells in an animal model. Transfusion (in press). doi:10.1111/j.1537-2995.2011.03184.x.
17. Peng K.-W., Frenzke M., Myers R., Soeffker D., Harvey M., Greiner S., Galanis E., Cattaneo R., Federspiel M.J., Russell S. Hum. Gene Ther. 2003, 14:1565-1577.
18. Piwnica-Worms D., Schuster D.P., Garbow J.R. Molecular imaging of host-pathogen interactions in intact small animals. Cell Microbiol. 2004, 6:319-331.
19. Räty J.K., Liimatainen T., Wirth T., Airenne K.J., Ihalainen T.O., Huhtala T., Hamerlynck E., Vihinen-Ranta M., Närvänen A., Ylä-Herttuala S., Hakumäki J.M. Magnetic resonance imaging of viral particle biodistribution in vivo. Gene Ther. 2006, 13:1440-1446.
20. Strable E., Finn M.G. Chemical modification of viruses and virus-like particles. Curr. Top. Microbiol. Immunol. 2009, 327:1-21.
21. Waehler R., Russell S.J., Curiel D.T. Engineering targeted viral vectors for gene therapy. Nat. Rev. Genet. 2007, 8:573-587.
22. Yamamoto M., Curiel D.T. Current issues and future directions of oncolytic adenoviruses. Mol. Ther. 2010, 18:243-250.
23. Yoshimura A., Ohnishi S.-I. Uncoating of influenza virus in endosomes. J. Virol. 1984, 51:497-504.